Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate

This publication has 46 references indexed in Scilit:

• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium
  Cardiovascular Research, 1994
• Cytosolic and Sarcoplasmic Reticulum-Associated Low Km, cGMP-Inhibited cAMP Phosphodiesterase in Mammalian Myocardium
  Biochemical and Biophysical Research Communications, 1993
• Comparison of the two classes of binding sites (A and B) of type I and type II cyclic‐AMP‐dependent protein kinases by using cyclic nucleotide analogs
  European Journal of Biochemistry, 1989
• A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart Failure
  New England Journal of Medicine, 1989
• Subsensitivity of the Failing Human Heart to Isoprenaline and Milrinoneo is Related to β-Adrenoceptor Downregulation
  Journal of Cardiovascular Pharmacology, 1988
• Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
  Circulation, 1985
• Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
  New England Journal of Medicine, 1983
• The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
  Circulation, 1983
• Hemodynamic Assessment of Amrinone
  New England Journal of Medicine, 1978